Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and ...

Please see full Prescribing Information, including Patient Information: <a ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as ...

Participants were assigned to one of three groups: lorundrostat 50 mg once daily; lorundrostat 50 mg once daily with the ...

A hormone disorder called primary aldosteronism may be driving as many as 1 in 5 cases of high blood pressure, according to ...

I’m sitting in my GP’s office, explaining for the sixth time that I know my hair loss, memory problems and missed periods aren’t normal. “I think you’re a bit stressed,” she tells me.

Primary aldosteronism has long been described as the hidden epidemic of cardiovascular medicine. It is the most common form ...

A new drug called baxdrostat may offer another treatment option for people who have both chronic kidney disease and difficult ...

Heart failure is serious, but a Penn State Health cardiologist says many patients can feel better and stay active with ...

Some common blood pressure medicines may offer extra protection for people with brain aneurysms, according to research ...

A diversified late-stage pipeline encompassing endothelin receptor antagonists, aldosterone synthase inhibitors such as lorundrostat, APOL1 ...